Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$7,641,803
+$4,261,139 QoQ
Shares Held
30,368
+95.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#1,056
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abundance Wealth Counselors holds $44,555,696 across 12 Drug Manufacturers - General names. ABBV ranks #1 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
30,368 | $7,641,803 | |
| 2 | JNJ |
Johnson & Johnson
|
23,066 | $5,858,072 | |
| 3 | AMGN |
Amgen Inc
|
14,911 | $5,399,571 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
91,814 | $5,290,322 | |
| 5 | NVS |
Novartis AG
|
32,213 | $5,048,421 | |
| 6 | LLY |
ELI LILLY & Co
|
4,027 | $4,830,105 | |
| 7 | GSK |
GSK plc
|
65,979 | $3,458,619 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,139 | $2,797,041 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,641,803 | 30,368 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,380,664 | 15,544 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,613,569 | 15,815 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,723,163 | 16,080 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,049,365 | 16,428 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $3,493,746 | 16,675 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,894,199 | 16,287 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,182,390 | 16,115 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,837,798 | 16,545 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,246,843 | 17,830 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,738,009 | 17,668 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,596,327 | 17,418 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,393,882 | 17,768 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $3,097,993 | 19,439 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,947,119 | 18,236 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,670,510 | 19,898 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,988,917 | 19,515 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,249,657 | 20,046 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,534,823 | 18,721 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,931,196 | 17,903 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,966,131 | 17,455 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,221,695 | 11,289 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,056,070 | 9,856 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $723,405 | 8,259 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $645,729 | 6,577 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||